Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Rikhia Chakraborty, Oliver A. Hampton, Harshal Abhyankar, Daniel J. Zinn, Amanda Grimes, Brooks Skull, Olive Eckstein, Nadia Mahmood, David A. Wheeler, Dolores Lopez-Terrada, Tricia L. Peters, John M. Hicks, Tarek Elghetany, Robert Krance, Poulikos I. Poulikakos, Miriam Merad, Kenneth L. McClain, Carl E. Allen, Williams D. Parsons
Published Apr 29, 2017 · Vol. 8, No. 28 · pp. 46065-46070
Theresa Link, Friederike Kuithan, Armin Ehninger, Jan Dominik Kuhlmann, Michael Kramer, Andreas Werner, Axel Gatzweiler, Barbara Richter, Gerhard Ehninger, Gustavo Baretton, Michael Bachmann, Pauline Wimberger, Katrin Friedrich
Published Apr 29, 2017 · Vol. 8, No. 33 · pp. 54592-54603
Hongmei Wu, Jiong Bi, Yan Peng, Lei Huo, Xiaobin Yu, Zhihui Yang, Yunyun Zhou, Li Qin, Yixiang Xu, Lan Liao, Yang Xie, Orla M. Conneely, Jos Jonkers, Jianming Xu
Published Apr 29, 2017 · Vol. 8, No. 33 · pp. 54364-54377